U.S. market Closed. Opens in 2 hours 6 minutes

JSPRW | Jasper Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue1.11M1.31M566.00K21.00KN/A
Gross Profit-1.11M-1.31M-566.00K-21.00KN/A
Operating Expenses68.86M51.20M36.83M20.68M4.45M
Selling, General & Admin17.08M16.57M11.41M4.80M1.09M
Research & Development51.78M34.63M25.42M15.88M3.62M
Other Operating ExpensesN/A586.00K-80.00K-111.00KN/A
Operating Income-68.86M-51.20M-36.83M-20.68M-4.71M
Other Expenses / Income4.40M13.51M6.20M-10.99M-277.00K
Before Tax Income-64.47M-37.69M-30.64M-31.67M-4.99M
Income Tax Expenses-1.63M-13.51M-6.65M-38.45K-277.00
Net Income-64.47M-24.17M-23.98M-31.67M-4.99M
Interest ExpensesN/A-13.51MN/AN/AN/A
Basic Shares Outstanding10.44M3.65M1.14M277.07KN/A
Diluted Shares Outstanding10.44M3.65M1.14M277.07KN/A
EBITDA-67.75M-64.12M-43.11M-9.81M-277.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-66.09M-51.20M-30.64M-31.71M-4.99M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙